This compound is an active pharmaceutical ingredient impurity, specifically a salt-like mixture formed between ambroxol and acefylline. It is primarily used as a reference standard or intermediate in pharmaceutical manufacturing and quality control processes.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 179118-73-1
Ambroxol
active pharmaceutical ingredient
4-(((2-Amino-3,5-dibromophenyl)methyl)amino)cyclohexan-1-ol--hydrogen chloride (1/1)
active pharmaceutical ingredient
(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)acetic acid--4-(((2-amino-3,5-dibromophenyl)methyl)amino)cyclohexan-1-ol (1/1)
active pharmaceutical ingredient
Ambroxol
active pharmaceutical ingredient
Oxytocein (A)
active pharmaceutical ingredient
Ritlecitinib
Janus kinase 3 inhibitor
Daridorexant hydrochloride
active pharmaceutical ingredient
Magnesium lactate dihydrate
magnesium supplement active ingredient
4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic acid
IPUHJDQWESJTGD-UHFFFAOYSA-N
CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)O.C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O